The Clinical Proteomic Tumor Analysis Consortium
First Annual Scientific Symposium
Connecting Genome Alterations to Cancer Biology with Proteomics
Natcher Conference Center (Building 45)
National Institutes of Health
November 13, 2013
On behalf of the National Cancer Institute, I am writing to invite you to the First Annual Clinical Proteomic Tumor Analysis Consortium (CPTAC) Scientific Symposium, sponsored by the National Cancer Institute (NCI). The purpose of this symposium, which consists of plenary and poster sessions, is for investigators from CPTAC community and beyond to share and discuss novel biological discoveries, analytical methods, and translational approaches using CPTAC data. All scientists who use, or wish to use CPTAC data are welcome to participate. Event will be held at the Natcher Conference Facility on the main campus of the National Institutes of Health in Bethesda, Maryland.
CPTAC is a consortium of proteogenomic centers to identify and annotate biological relevance of proteins derived from cancer genomes. A unique feature of the program is the utilization of genomically characterized tumors such as those from The Cancer Genome Atlas (TCGA). CPTAC has recently begun deep proteomic interrogation of TCGA tumors, with the first datasets anticipated to be released in 4Q/2013, followed by two additional sets in 2Q/2014. Preliminary results are shedding new insights on the intricate relationships between genomic abnormalities and cancer phenotypes, essential to our ability to understand basic biological processes and determine the molecular basis of cancer.
CPTAC is a true community resource and I hope investigators like you will be able to participate in this important Symposium, as data analysis and dissemination of such critical data through an open conference is paramount in translating NCI funded discoveries into diagnostic and treatment modalities.
Henry Rodriguez, Ph.D., M.B.A.
Office of Cancer Clinical Proteomics Research
|Deadline for Hotel Reservations||Friday, October 25, 2013|